Brain+
0.096
DKK
-0.62 %
BRAINP
First North Denmark
Biotechnology & Pharmaceuticals
Health Care
3 following
-0.62%
+9.3%
+1.47%
+21.11%
-47.07%
-48.92%
-94.69%
-
-96.5%
www.brain-plus.com/investor
Brain+ are a pharmaceutical company. The company specializes in research and development for the treatment of dementia and Alzheimer's. The product portfolio includes, for example, cognitive stimulation therapy. In addition to the main business, service and associated ancillary services are also offered. The business is run with the largest presence in Europe. Brain+ is headquartered in Copenhagen.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Denmark
BRAINP
Daily low / high price
0.092 / 0.096
DKK
Market cap
20.49M DKK
Turnover
2.19K DKK
Volume
23K
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Kim Baden-Kristensen | 15.4 % | 15.4 % |
| Ulrik Ditlev Eriksen | 9.3 % | 9.3 % |
ShowingAll content types
Brain+ A/S: Brain+ secures its first multi-year sales contract for Ayla - your CST Assistant with Syddjurs municipality
Brain+ A/S: Invitation to Investor Webinar on Monday 25th of November at 15:30: Update on commercial status and new opportunities
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools